Glutathione reductase assay kit and its preparation method and application
By using the pentose phosphate regeneration pathway formed by oxidative Coenzyme II and glucose-6-phosphate dehydrogenase in the glutathione reductase kit, the problem of poor stability of the kit during low temperature storage is solved, and a higher level of stability is achieved accuracy and stability of the determination.
Patent Information
- Application Number
- CN202210622713.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-06-01
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2042-06-01
AI Technical Summary
The existing glutathione reductase kits have poor stability during low temperature storage, and the reduced coenzyme of liquid dual reagents is easily oxidized, resulting in insufficient determination accuracy and stability.
The reduced coenzyme II is replaced by oxidative Coenzyme II (NADP+), and the pentose phosphate regeneration pathway is formed through glucose-6-phosphate and glucose-6-phosphate dehydrogenase to ensure that the reaction is in a slow reaction and equilibrium state during low temperature storage. During use, the stability and accuracy of the kit are improved by reducing oxidative Coenzyme II by glucose-6-phosphate dehydrogenase.
It significantly improves the stability and determination accuracy of the kit, avoids the decomposition of coenzymes during low-temperature storage, and enhances the service life of the reagent and the reliability of the detection results.
Smart Images

Figure BDA0003675197530000061 
Figure BDA0003675197530000071 
Figure BDA0003675197530000072
Abstract
Description
Technical Field
[0001] The invention relates to a glutathione reductase assay kit and a preparation method and application thereof, belonging to the technical field of biochemical reagent assay. Background Art
[0002] Glutathione reductase (GR) is a flavin enzyme that catalyzes oxidized glutathione (GSSG) to reduced glutathione (GSH). Reduced glutathione plays an important role in maintaining the integrity of red blood cell membranes and preventing hemoglobin oxidation. Glutathione reductase is localized in the microsomes and cytosol, so it is contained in the tissue cells of various organs. In the normal metabolic process of the body, the body has an effective antioxidant defense system, and the continuously generated oxygen free radicals are continuously removed by the antioxidant system, thereby maintaining the concentration at physiological levels. The glutathione antioxidant enzyme system is one of the main antioxidant systems in human cells. At present, the detection of glutathione reductase has been applied to the detection of liver diseases, nutritional assessment (riboflavin status), and hereditary deficiency stages.
[0003] At present, the commonly used detection methods include enzyme-linked immunosorbent assay, ultraviolet enzyme method, fluorescence spectrophotometry, glutathione substrate method, etc. The ultraviolet enzyme method is the main method promoted in China. Glutathione reductase catalyzes the reduction of oxidized glutathione to reduced glutathione, and at the same time, reduced coenzyme II (NADPH, reduced nicotinamide adenine dinucleotide phosphate) is oxidized to coenzyme II (NADP + ). NADPH has a specific absorption peak at a wavelength of 340nm, and its oxidation rate is proportional to the activity of GR in serum. The rate of decrease of NADPH absorbance at 340nm can be measured to calculate the GR activity. The UV enzymatic glutathione reductase kit in the prior art mainly includes dry powder reagents and liquid double reagents. The former needs to be dissolved with buffer and distilled water before use. The dissolved reagent solution can only be stored for two days at 2-8°C, which is very inconvenient to use, and a large amount of waste will occur if it is not used up after re-dissolution; the latter has the disadvantages of poor stability and poor anti-interference ability.
[0004] Chinese invention patent CN 111321198 A discloses a glutathione reductase assay kit and its preparation method and application. The kit includes reagent R1 and reagent R2. The reagent R1 includes: phosphate buffer, ascorbic acid oxidase, pyruvate oxidase, potassium ferrocyanide, oxidized glutathione, MgCl2, FAD, preservative and surfactant; the reagent R2 includes glycine buffer, NADPH, preservative and protective agent; by adding EGTA and dithiothreitol to the reagent, the linear range of the kit can be expanded and the stability of the kit can be improved; the kit can accurately measure glutathione reductase. Reduced coenzyme II is used in the kit. Reduced coenzyme II is an important coenzyme. In organisms, NADPH is mainly synthesized through the central carbon metabolism pathway, such as the pentose phosphate pathway is the main synthesis pathway of NADPH. In this pathway, glucose-6-phosphate dehydrogenase catalyzes glucose-6-phosphate to generate glucose-6-phosphate delta lactone and NADPH. NADPH is an electron donor for all eukaryotes, bacteria, and archaea, and plays an important role in the redox reactions and oxidative defense mechanisms of organisms. More importantly, it plays a driving role in most enzymatic reactions of biosynthesis, providing reducing power for biosynthesis. NADPH provides reducing power for the reduction of oxidized glutathione (GSSG) to reduced glutathione (GSH), and plays an important role in the determination of glutathione reductase. However, when reduced coenzyme II is stored in liquid form, it is easily oxidized to oxidized coenzyme II (NADP + ), which is one of the main reasons for the poor stability of liquid dual reagents. Summary of the invention
[0005] In view of the above prior art, the present invention provides a glutathione reductase assay kit with strong stability.
[0006] The present invention is achieved through the following technical solutions:
[0007] A glutathione reductase assay kit comprises a reagent R1 and a reagent R2, wherein the volume ratio of the reagent R1 to the reagent R2 is 1-6:1; the reagent R1 is composed of the following components: 5-100 mmol / L Tris buffer, 1-10 KU / L ascorbic acid oxidase, 1-10 KU / L pyruvate oxidase, 5-25 mg / L potassium ferrocyanide, 1-10 mmol / L MgCl2, 0.05-3 mmol / L glucose-6-phosphate, NADP + 0.1~3mmol / L, glucose-6-phosphate dehydrogenase 0.1~5KU / L, EDTA 0.1~5mmol / L, preservative 0.1~1g / L, surfactant 1~10mL / L, protective agent 1~10g / L, the balance is water;
[0008] The reagent R2 is composed of the following components: 50-500 mmol / L of phosphate buffer, 5-50 mmol / L of oxidized glutathione, 0.1-5 mmol / L of EDTA, 0.1-1 g / L of preservative, 1-10 g / L of protective agent, and the balance is water.
[0009] Preferably, the volume ratio of the reagent R1 to the reagent R2 is 5:1.
[0010] Preferably, the reagent R1 is composed of the following components: Tris buffer 20mmol / L, ascorbate oxidase 5KU / L, pyruvate oxidase 4KU / L, potassium ferrocyanide 6mg / L, MgCl2 5mmol / L, glucose-6-phosphate 0.6mmol / L, NADP + 0.9mmol / L, glucose-6-phosphate dehydrogenase 1.8KU / L, EDTA 1mmol / L, preservative 0.5g / L, surfactant 2mL / L, protective agent 6g / L, and the balance is water.
[0011] Preferably, the reagent R2 is composed of the following components: 250 mmol / L phosphate buffer, 26 mmol / L oxidized glutathione, 1 mmol / L EDTA, 0.5 g / L preservative, 3 g / L protective agent, and the balance is water.
[0012] Furthermore, the preservative is selected from any one or more of sodium azide, PC300 and thimerosal.
[0013] Furthermore, the surfactant is selected from any one or more of Tween 20, Tween 80, TritonX-100, Emulgen B66, Brij-35 and NP-1055.
[0014] Furthermore, the protective agent is selected from any one or more of trehalose, dextran, sucrose, mannitol, glycerol and bovine serum albumin.
[0015] Preferably, the preservative is sodium azide; the surfactant is TX-100; the protective agent in the reagent R1 is sucrose, bovine serum albumin and glycerol, and the weight ratio of the three is 1-30:1:1-20, more preferably 5:1:2; the protective agent in the reagent R2 is trehalose, mannitol and glycerol, and the weight ratio of the three is 1-10:1:1-10, more preferably 2:1:2.
[0016] The preparation method of the glutathione reductase assay kit comprises the following steps:
[0017] (1) Preparation of reagent R1: Take an appropriate amount of water, add the components in reagent R1, stir and dissolve, adjust the pH to 7.5-9.5 with hydrochloric acid or sodium hydroxide solution, and make up to volume;
[0018] (2) Preparation of reagent R2: Take an appropriate amount of water, add the components in reagent R1, stir to dissolve and mix, adjust the pH to 6.5-7.5 with hydrochloric acid or sodium hydroxide solution, and make up to volume.
[0019] The glutathione reductase assay kit is used in non-disease assays (non-medical diagnosis purposes) of glutathione reductase.
[0020] The glutathione reductase assay kit of the present invention is improved on the basis of CN 111321198 A. Compared with CN111321198 A, the substantial improvement mainly lies in that the present invention replaces the reduced coenzyme II (NADPH) with the oxidized coenzyme II (NADP + ), glucose-6-phosphate and glucose-6-phosphate dehydrogenase, forming the pentose phosphate regeneration pathway of reduced coenzyme II. The regeneration reaction of the reagent during low-temperature storage is in a slow reaction and reaction equilibrium state. When using oxidized coenzyme II (NADP + ) can be reduced to reduced coenzyme II under the action of glucose-6-phosphate dehydrogenase, thereby effectively solving the problem of reduced coenzyme II being oxidized during low-temperature storage and improving the stability of the kit. In addition, the oxidized glutathione of the present invention is in reagent R2 (CN 111321198 A is in reagent R1), eliminating the interference of substances in the serum on the detection before reading the absorbance, using the rate method for detection, improving the accuracy of the reagent, and further optimizing the performance of the kit.
[0021] The glutathione reductase assay kit of the present invention has pyruvate oxidase and ascorbate oxidase in the reagent which can eliminate the interference of pyruvate and ascorbate in serum, thus improving the accuracy of the reagent. Potassium ferrocyanide can convert ferrous ions in hemoglobin into ferric ions, generate stable cyanomethemoglobin, and reduce the influence on the test results of the reagent. Glucose-6-phosphate, NADP + It can generate reduced coenzyme II with glucose-6-phosphate dehydrogenase, providing stable reducing power for the reaction, effectively avoiding the decomposition of NADPH during low-temperature storage, and improving the stability of the reagent. DETAILED DESCRIPTION
[0022] The present invention will be further described below in conjunction with the embodiments. However, the scope of the present invention is not limited to the following embodiments. It will be appreciated by those skilled in the art that various changes and modifications may be made to the present invention without departing from the spirit and scope of the present invention.
[0023] The instruments, reagents, and materials involved in the following examples, unless otherwise specified, are all conventional instruments, reagents, and materials already available in the prior art and can be obtained through regular commercial channels. The experimental methods and detection methods involved in the following examples, unless otherwise specified, are all conventional experimental methods and detection methods already available in the prior art.
[0024] Example 1
[0025] A glutathione reductase assay kit comprises a reagent R1 and a reagent R2, wherein the volume ratio of the reagent R1 to the reagent R2 is 5:1; wherein the reagent R1 is composed of the following components: Tris buffer 5mmol / L, ascorbic acid oxidase 1KU / L, pyruvate oxidase 1KU / L, potassium ferrocyanide 5mg / L, MgCl2 1mmol / L, preservative 0.1g / L, glucose-6-phosphate 0.05mmol / L, NADP + 0.1mmol / L, glucose-6-phosphate dehydrogenase 0.1KU / L, EDTA 0.1mmol / L, and the balance is water.
[0026] Reagent R2 is composed of the following components: phosphate buffer 50mmol / L, oxidized glutathione 5mmol / L, EDTA 0.1mmol / L, preservative 0.1g / L, and the balance is water.
[0027] The preservative is sodium azide (the same below).
[0028] The preparation method is:
[0029] (1) Preparation of reagent R1: Take an appropriate amount of water, add each component in reagent R1, stir and dissolve (add one component, stir and dissolve, then add the next component), adjust the pH to 8.5 with hydrochloric acid or sodium hydroxide solution, and make up to volume;
[0030] (2) Preparation of reagent R2: Take an appropriate amount of water, add each component in reagent R1, stir and dissolve (add one component, stir and dissolve, then add the next component), adjust the pH to 7.0 with hydrochloric acid or sodium hydroxide solution, and make up to volume.
[0031] Example 2
[0032] A glutathione reductase assay kit comprises a reagent R1 and a reagent R2, wherein the volume ratio of the reagent R1 to the reagent R2 is 5:1; wherein the reagent R1 is composed of the following components: Tris buffer 100 mmol / L, ascorbic acid oxidase 10 KU / L, pyruvate oxidase 10 KU / L, potassium ferrocyanide 25 mg / L, MgCl2 10 mmol / L, preservative 1 g / L, glucose-6-phosphate 2.5 mmol / L, NADP + 5mmol / L, glucose-6-phosphate dehydrogenase 5KU / L, EDTA 5mmol / L, and the balance is water.
[0033] Reagent R2 is composed of the following components: phosphate buffer 500mmol / L, oxidized glutathione 50mmol / L, EDTA 5mmol / L, preservative 1g / L, and the balance is water.
[0034] The preparation method is the same as Example 1.
[0035] Example 3
[0036] The difference from Example 1 is that the reagent R1 also includes a surfactant TX-100 with a concentration of 1 ml / L.
[0037] Example 4
[0038] The difference from Example 2 is that the reagent R1 also includes a surfactant TX-100 with a concentration of 10 ml / L.
[0039] Example 5
[0040] The difference from Example 1 is that reagent R1 also includes a protective agent, which is composed of sucrose, bovine serum albumin and glycerol, and the weight ratio of the three is 1:1:1; reagent R2 also includes a protective agent, which is composed of trehalose, mannitol and glycerol, and the weight ratio of the three is 1:1:1.
[0041] Example 6
[0042] The difference from Example 2 is that reagent R1 also includes a protective agent, which is composed of sucrose, bovine serum albumin and glycerol, and the weight ratio of the three is 30:1:20; reagent R2 also includes a protective agent, which is composed of trehalose, mannitol and glycerol, and the weight ratio of the three is 10:1:10.
[0043] Example 7
[0044] A glutathione reductase assay kit comprises a reagent R1 and a reagent R2, wherein the volume ratio of the reagent R1 to the reagent R2 is 5:1; wherein the reagent R1 is composed of the following components: Tris buffer 20 mmol / L, ascorbic acid oxidase 5 KU / L, pyruvate oxidase 4 KU / L, potassium ferrocyanide 6 mg / L, MgCl2 5 mmol / L, glucose-6-phosphate 0.6 mmol / L, NADP + 0.9mmol / L, glucose-6-phosphate dehydrogenase 3KU / L, EDTA 1mmol / L, preservative 0.5g / L, surfactant TX-1002mL / L, protective agent 6g / L, and the balance is water. The protective agent is composed of sucrose, bovine serum albumin and glycerol, and the weight ratio of the three is 5:1:2.
[0045] Reagent R2 is composed of the following components: phosphate buffer 250mmol / L, oxidized glutathione 26mmol / L, EDTA 1mmol / L, preservative 0.5g / L, protective agent 3g / L, and the balance is water. The protective agent is composed of trehalose, mannitol and glycerol, and the weight ratio of the three is 2:1:2.
[0046] The preparation method is the same as Example 1.
[0047] Comparative Example 1
[0048] The difference from Example 7 is that the concentration of glucose-6-phosphate dehydrogenase in reagent R1 is 0.08 KU / L.
[0049] Comparative Example 2
[0050] The difference from Example 7 is that the concentration of glucose-6-phosphate dehydrogenase in reagent R1 is 6 KU / L.
[0051] Comparative Example 3
[0052] The difference from Example 7 is that the concentration of the Tris buffer in reagent R1 is 120 mmol / L, and the concentration of the phosphate buffer in reagent R2 is 520 mmol / L.
[0053] Comparative Example 4
[0054] The difference from Example 7 is that the buffer substance Tris buffer in reagent R1 is replaced by glycine buffer, and the buffer substance phosphate buffer in reagent R2 is replaced by PIPES.
[0055] Comparative Example 5
[0056] The difference from Example 7 is that the concentration of glucose-6-phosphate in reagent R1 is 0.02 mmol / L.
[0057] Comparative Example 6
[0058] The difference from Example 7 is that the concentration of glucose-6-phosphate in reagent R1 is 1.2 mmol / L.
[0059] Comparative Example 7
[0060] The difference from Example 7 is that the concentration of glucose-6-phosphate in reagent R1 is 3 mmol / L.
[0061] Comparative Example 8
[0062] The difference from Example 7 is that the "glucose-6-phosphate 0.6mmol / L, NADP + 0.9mmol / L, glucose-6-phosphate dehydrogenase 3KU / L" was replaced by NADPH 0.9mmol / L.
[0063] Comparative Example 9
[0064] It is a commercially available glutathione kit (glutathione substrate method). The detection principle is: in the presence of reduced nicotinamide adenine dinucleotide phosphate (NADPH), glutathione reductase can catalyze the degradation of oxidized glutathione (GSSG), while NADPH is oxidized to NADP + The activity of GR was calculated by measuring the decrease in absorbance at a wavelength of 340 nm.
[0065] The present invention is improved on the basis of CN 111321198 A. For intuitive comparison, the detection conditions of various experiments on the performance of the kit of the present invention are as consistent as possible with those of CN 111321198 A (the detection conditions are listed in the following machine parameters, which are consistent with the most important detection conditions, detection methods, wavelengths, and reagent volume ratios in CN 111321198 A).
[0066] Experiment 1 Linear range test
[0067] Use high-value samples close to the upper limit of the linear range and low-value samples close to the lower limit of the linear range to mix into at least 5 dilution concentrations (Xi), repeat the test 3 times for each concentration, and calculate the mean value (Yi) of the test results. Use the dilution concentration (Xi) as the independent variable and the mean value (Yi) of the test results as the dependent variable to calculate the linear regression equation.
[0068] The correlation coefficient (r) of linear regression was calculated according to the following formula.
[0069]
[0070] Where:
[0071] Xi——dilution concentration;
[0072] Yi——the mean of each concentration test result;
[0073] i——1, 2, 3,..., n;
[0074] n——fixed sample size.
[0075] The reagent in the present invention is liquid and can be used directly. The determination method is shown in Table 1, and the determination conditions are shown in Table 2.
[0076] Table 1
[0077] method Rate Method specimen 10μl Reaction time 10min temperature 37℃ Reagent 1 / Reagent 2 200μL / 40μL First metering point Read 1 min after adding reagent 2 wavelength 340nm Sub-wavelength 405nm Second metering point Read 4 minutes after adding reagent 2
[0078] Table 2
[0079]
[0080] Calculation formula:
[0081]
[0082] According to the known sample activities, the corresponding sample activities of groups 1-6 are 60U / L, 120U / L, 180U / L, 240U / L, and 300U / L, respectively. Finally, the activities of the samples in Examples 1-4, Example 7, and Comparative Examples 1, 2, 5, 6, and 8 are obtained, as shown in Table 3.
[0083] Table 3
[0084]
[0085] As shown in Table 3, Examples 2 to 4, Example 7, Comparative Examples 2 and 6, and Comparative Example 9 of the commercial reagent in the present invention can all accurately measure glutathione reductase with an activity of less than 300 U / L, among which Example 7 is the best, and the final measured value is close to the theoretical value; as shown in Example 2, which is better than Example 1, the increase in the concentration of the reagent components is conducive to the improvement of the reagent linearity; as shown in Example 4, which is better than Example 3, the addition of the surfactant TX-100 plays a positive role in improving the reagent linearity; as shown in Comparative Example 2, which is better than Comparative Example 1, and Comparative Example 6, which is better than Comparative Example 5, the increase in the content of the catalytic enzyme glucose-6-phosphate is conducive to the increase in the content of the substrate NADPH, thereby facilitating the improvement of the reagent linearity, and the optimal catalytic enzyme concentration is selected under the requirements of the reagent linear range and cost, and for the substrate glucose-6-phosphate, within a certain range, the reagent linear range increases with the increase of the substrate concentration, and decreases with the increase of the concentration beyond this range, because at a high concentration, the unreacted glucose-6-phosphate reacts with the newly generated NADP +The reaction is carried out again, that is, the product is consumed, resulting in a low absorbance measurement value, which is not conducive to improving the linearity of the reagent. Therefore, in addition to the requirements of the linear range and cost of the reagent, the selection of the optimal content of the substrate glucose-6-phosphate should also make it consumed in the first step of the reaction and should not interfere with the reaction catalyzed by glutathione reductase; it can be seen from the fact that Comparative Example 9 is similar to Example 7 that the linear range of the reagent of the present invention can fully meet market demand.
[0086] Experiment 2 37℃ stability test
[0087] Test method: Reagent 1 and reagent 2 in Examples 1 to 7 and Comparative Examples 1 to 9 were placed in a 37°C constant temperature incubator for accelerated testing. The test sample was a glutathione reductase quality control product with a target value of 57.6U / L. The reagents in the incubator were taken out daily and tested in a Hitachi 7600 automatic biochemical analyzer. Each reagent was tested three times each time, and the average value was calculated and recorded. The 37°C accelerated stability of the reagent was monitored according to the numerical changes of the quality control product. The test was continued for 7 days. The test results of some embodiments and comparative examples are statistically shown in Table 4.
[0088] Table 4
[0089]
[0090] As can be seen from Table 4, in the 37°C accelerated test, Example 7 has the best stability, and Examples 5 and 6 have better stability than Examples 1 and 2. It can be seen that the protective agent plays a very positive role in improving the stability of the reagent, and the type and proportion of the protective agent are optimal in Example 7; from the comparison of the data of Comparative Examples 3 and 4 with Example 7, it can be seen that the type and concentration of the buffer have a greater impact on the stability of the reagent, and the buffer concentration and type in Example 7 are the best; from the comparison of the data of Comparative Examples 6 and 8 with Example 7, it can be seen that for the acquisition of NADPH, indirect generation through the pentose phosphate pathway can greatly improve the stability of the reagent compared to direct addition.
[0091] Experiment 3: 4℃ opening stability test
[0092] Test method: Reagent 1 and reagent 2 in Table 5 were placed in the 4°C reagent bin of Hitachi 7600 automatic biochemical analyzer. The test sample was a glutathione reductase quality control product with a target value of 57.6U / L. The reagents in the 4°C reagent bin were taken out for testing every day. Each reagent was tested three times each time, and the average value was calculated and recorded. The 4°C opening stability of the reagent was monitored based on the numerical changes of the quality control product. The test was continued for 15 days, and the test results were statistically recorded in Table 5.
[0093] Table 5
[0094]
[0095] It can be seen from Table 5 that in the 4°C opening stability test, Example 7 has the best stability, and the stability of Examples 5 and 6 is better than that of Examples 1 and 2. It can be seen that the addition of the protective agent plays a very positive role in the 4°C opening stability of the reagent, and the type and proportion of the protective agent are optimal in Example 7; from the comparison of the data of Comparative Examples 3 and 4 with Example 7, it can be seen that the type and concentration of the buffer have a greater impact on the 4°C opening stability of the reagent, and the buffer concentration and type in Example 7 are the best; from the comparison of the data of Comparative Examples 6, Example 7 and Comparative Example 8, it can be seen that for the acquisition route of NADPH in the reagent, indirect generation through reaction can improve the 4°C opening stability of the glutathione reductase detection reagent more than direct acquisition.
[0096] Experiment 4: Stability during shelf life
[0097] Reagent 1 and reagent 2 in Examples 1-7 and Comparative Examples 1-8 were placed in a 4°C refrigerator for accelerated testing. The test sample was a glutathione reductase quality control product with a target value of 57.6U / L. The reagents in the refrigerator were taken out at 0, 1, 2, 3, 6, 9, and 12 months and tested in a Hitachi 7600 automatic biochemical analyzer. Each reagent was tested three times each time, and the average value was calculated and recorded. The shelf life stability of the reagent was monitored based on the numerical changes of the quality control product. The test was performed for 12 months, and the test results are statistically shown in Table 6.
[0098] Table 6
[0099]
[0100]
[0101] As shown in Table 6, in the shelf life stability test, Example 7 has the best stability, and Examples 5 and 6 have better stability than Examples 1 and 2. It can be seen that the addition of the protective agent plays a very positive role in the shelf life stability of the reagent, and the type and proportion of the protective agent are optimal in Example 7; from the comparison of the data of Comparative Examples 3 and 4 with Example 7, it can be seen that the type and concentration of the buffer have a greater impact on the shelf life stability of the reagent, and the concentration and type of the buffer in Example 7 are the best; from the comparison of the data of Comparative Examples 6, Example 7 and Comparative Example 8, it can be seen that for the acquisition route of NADPH in the reagent, indirect generation through reaction can improve the shelf life stability of the glutathione reductase detection reagent more than direct acquisition.
[0102] It can be seen from Tables 4, 5 and 6 that the glutathione reductase reagent of the present invention has good stability.
[0103] Experiment 5: Accuracy Test
[0104] Use no less than 40 human samples of different concentrations within the detection concentration range, use the specified analysis system as the comparison method, each sample is tested according to the test agent operation method and the comparison method, and the linear regression method is used to calculate the correlation coefficient (r) of the two groups of results and the relative deviation of each concentration point. In this patent, the test results of Example 7 are used as the target value, and the relative deviation of 40 data is calculated respectively. The correlation coefficient r is required to be not less than 0.99 and the relative deviation is not more than ±10%. The final relative deviation results are shown in Table 7.
[0105] Table 7
[0106]
[0107]
[0108] From the data comparison between Comparative Example 9 and Example 7 in Table 7, it can be seen that the reagent of the present invention and the commercially available glutathione reductase reagent have a high correlation in accuracy and can meet market demand.
[0109] The above examples are provided to those skilled in the art to fully disclose and describe how to make and use the claimed embodiments, and are not intended to limit the scope of the disclosure herein. Modifications that are obvious to those skilled in the art will fall within the scope of the appended claims.
Claims
1. A glutathione reductase assay kit, Features: The reagent R1 and the reagent R2 have a volume ratio of 5:
1. The reagent R1 is composed of the following components: Tris buffer 20 mmol / L, ascorbate oxidase 5 KU / L, pyruvate oxidase 4 KU / L, potassium ferrocyanide 6 mg / L, MgCl 2 5mmol / L, glucose-6-phosphate 0.6mmol / L, NADP + 0.9mmol / L, glucose-6-phosphate dehydrogenase 1.8KU / L, EDTA 1mmol / L, preservative 0.5g / L, surfactant 2mL / L, protective agent 6g / L, and the balance is water; the reagent R2 is composed of the following components: phosphate buffer 250mmol / L, oxidized glutathione 26mmol / L, EDTA 1mmol / L, preservative 0.5g / L, protective agent 3g / L, and the balance is water.
2. The glutathione reductase assay kit according to claim 1, Features: The preservative is selected from any one or more of sodium azide, PC300 and thimerosal.
3. The glutathione reductase assay kit according to claim 1, Features: The surfactant is selected from any one or more of Tween 20, Tween 80, TritonX-100, Emulgen B66, Brij-35 and NP-1055.
4. The glutathione reductase assay kit according to claim 1, Features: The protective agent is selected from any one or more of trehalose, dextran, sucrose, mannitol, glycerol and bovine serum albumin.
5. The glutathione reductase assay kit according to claim 4, Features: The protective agent in the reagent R1 is sucrose, bovine serum albumin and glycerol, and the weight ratio of the three is 1-30:1:1-20; the protective agent in the reagent R2 is trehalose, mannitol and glycerol, and the weight ratio of the three is 1-10:1:1-10.
6. A method for preparing a glutathione reductase assay kit according to any one of claims 1 to 5, It is characterized in that Here are the steps: (1) Preparation of reagent R1: Take an appropriate amount of water, add the components in reagent R1, stir and dissolve, adjust the pH to 7.5-9.5 with hydrochloric acid or sodium hydroxide solution, and make up to volume; (2) Preparation of reagent R2: Take an appropriate amount of water, add the components in reagent R2, stir to dissolve and mix, adjust the pH to 6.5-7.5 with hydrochloric acid or sodium hydroxide solution, and make up to volume.
7. Use of the glutathione reductase assay kit according to any one of claims 1 to 5 in non-disease assays of glutathione reductase.
Citation Information
Patent Citations
Glutathione reductase determination kit, and preparation method and applications thereof
CN111321198A
Glutathione reductase assay kit and preparation method and application thereof
CN108828215A
Glutathione reductase detection reagent kit and application
CN110734952A
Reagent for eliminating endogenous glucose interference, application thereof and method for eliminating endogenous glucose interference
CN112159833A
Detection methods of NADP(h) using mbfp
US20140273011A1
